What We're Reading
Industry reads hand-picked by our editors
Jun 30, 2026
-
The Wall Street Journal
Biotech Investor Pumps the Brakes on AI Drug Discovery
-
Reuters
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
-
South China Morning Post
Hong Kong draws royalties giant as mainland China biotech licensing heats up
Jun 29, 2026
Jun 26, 2026
-
The Wall Street Journal
InSilico Is on a Mission: Be No. 1 in China, Create ‘God Drug’ With AI
-
Quanta Magazine
Why the Human Genome’s Tangled Physicality May Confound AI
-
The Financial Times
Brussels launches antitrust probe into French drugmaker Sanofi
-
Stat
Jails are the frontline in fielding dangerous new type of drug withdrawal
Jun 25, 2026
-
The Financial Times
Patent cliffs aren’t the only driver of biotech M&A boom
-
Bloomberg
Crispr Pioneer Doudna Questions AI’s Role in Medical Innovation
-
Fierce Pharma
Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
-
Stat
Biosecure didn’t stop China’s rise in biotech. Some lawmakers want to do more
Jun 24, 2026
Jun 23, 2026
Jun 22, 2026
-
MIT Technology Review
Brain-computer interface trials are taking off
-
Associated Press
Utah marks a year of battling measles, with no clear end in sight
-
Science
Big Ebola outbreak puts spotlight on little-known virus
